• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.42% Nasdaq Up 0.43%

    Neurocrine Biosciences Inc. (NBIX)

    -NasdaqGS
    42.87 Up 0.52(1.23%) 1:41PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:42.35
    Open:42.67
    Bid:42.86 x 100
    Ask:42.90 x 200
    1y Target Est:52.00
    Beta:-0.91
    Earnings Date:Aug 4 - Aug 10 (Est.)
    Day's Range:41.62 - 43.39
    52wk Range:12.63 - 45.36
    Volume:384,934
    Avg Vol (3m):975,277
    Market Cap:3.66B
    P/E (ttm):N/A
    EPS (ttm):-0.65
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NBIX

    Comparison

    Symbol% ChgMkt Cap
    NBIXUp 1.23%3.66B
    ABTDown 0.10%72.79B
    LLYDown 0.32%82.28B
    PFEDown 0.17%212.01B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):182.98
    Ex-Dividend Date:29-Dec-95

    Analysts

    Annual EPS Est (Dec-15) :-0.86
    Quarterly EPS Est (Jun-15) :-0.29
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):4.58

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Neurocrine Biosciences, Inc. discovers and develops pharmaceuticals for the treatment of neurological and endocrine-related diseases and disorders in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback